🇺🇸 non-renin angiotensin system blockers in United States

non-renin angiotensin system blockers (non-renin angiotensin system blockers) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

non-renin angiotensin system blockers in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is non-renin angiotensin system blockers approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for non-renin angiotensin system blockers in United States?

Hospital Authority, Hong Kong is the originator. The local marketing authorisation holder may differ — check the official source linked above.